Canaccord Genuity Reiterates a 'Buy' on OraSure (OSUR); Congress Shows Support
Tweet
Share
E-mailGet Alerts OSUR Hot Sheet
Price: $3.88 +3.74%
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
9 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity reiterates a 'Buy' on OraSure Technologies (NASDAQ: OSUR) price target of $4.00.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR as Congress recently showed bi-partisan support for new CDC testing guidelines for HCV screening. An age-based testing recommendation could present a target opportunity of approximately 80 million baby boomers."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $9.69 yesterday.
Analyst, Jeffrey Frelick, said, "We reiterate our rating on OSUR as Congress recently showed bi-partisan support for new CDC testing guidelines for HCV screening. An age-based testing recommendation could present a target opportunity of approximately 80 million baby boomers."
For an analyst ratings summary and ratings history on OraSure Technologies click here. For more ratings news on OraSure Technologies click here.
Shares of OraSure Technologies closed at $9.69 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Rockwell Automation (ROK) PT Lowered to $490 at DA Davidson
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
